Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Bone Marrow Transplantation
|
November 14, 2017
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome
V Wais, L Kündgen, S R Bohl, et al.
Leukemia
|
December 27, 2016
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
J Krönke, F Kuchenbauer, M Kull, et al.
Bone Marrow Transplantation
|
March 8, 2016
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT
S Bohl, S von Harsdorf, M Mulaw, et al.
Leukemia
|
April 15, 2018
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
S Rudat, A Pfaus, Y Y Cheng, et al.
Annals of Hematology
|
March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)
K M Kortüm, C Langer, J Monge, et al.
Epilepsy & Behavior : E&B
|
April 19, 2023
The effect of responsive neurostimulation (RNS) on neuropsychiatric and psychosocial outcomes in drug-resistant epilepsy
Dale Tager, Deepa Panjeti-Moore, Jimmy C Yang, et al.
Brain Communications
|
May 20, 2024
Targeting thalamocortical circuits for closed-loop stimulation in Lennox-Gastaut syndrome
Aaron E L Warren, Christopher R Butson, Matthew P Hook, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
Leukemia
|
January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
N Jahn, M Agrawal, L Bullinger, et al.
Leukemia
|
November 14, 2013
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
M A Dawson, E J Gudgin, S J Horton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Bone Marrow Transplantation
|
November 14, 2017
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome
V Wais, L Kündgen, S R Bohl, et al.
Leukemia
|
December 27, 2016
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
J Krönke, F Kuchenbauer, M Kull, et al.
Bone Marrow Transplantation
|
March 8, 2016
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT
S Bohl, S von Harsdorf, M Mulaw, et al.
Leukemia
|
April 15, 2018
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
S Rudat, A Pfaus, Y Y Cheng, et al.
Annals of Hematology
|
March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)
K M Kortüm, C Langer, J Monge, et al.
Epilepsy & Behavior : E&B
|
April 19, 2023
The effect of responsive neurostimulation (RNS) on neuropsychiatric and psychosocial outcomes in drug-resistant epilepsy
Dale Tager, Deepa Panjeti-Moore, Jimmy C Yang, et al.
Brain Communications
|
May 20, 2024
Targeting thalamocortical circuits for closed-loop stimulation in Lennox-Gastaut syndrome
Aaron E L Warren, Christopher R Butson, Matthew P Hook, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
Leukemia
|
January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
N Jahn, M Agrawal, L Bullinger, et al.
Leukemia
|
November 14, 2013
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
M A Dawson, E J Gudgin, S J Horton, et al.
Page
of 8